Natalizumab in the treatment of multiple sclerosis. Experience of the Moscow Multiple Sclerosis Center (MMSC)

Authors: E. V. Popova, A. N. Boyko, M. V. Davydovskaya, O. V. Boyko, N. V. Khachanova

Source: Медицинский совет, Vol 0, Iss 10, Pp 52-55 (2014)

Subject Terms: рассеянный склероз, натализумаб, моно-клональные антитела, прогрессирующая мультифокаль-ная лейкоэнцефалопатия, multiple sclerosis, natalizumab, monoclonal antibodies, progressive multifocal leukoencephalopathy, Medicine

File Description: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/658; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

Access URL: https://doaj.org/article/b4a69e5ffc5d4879addff78e3d6efda2